Introduction
Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, was first characterized as a definite clinicopathologic entity in 1969 [1] . RDD is a self-limited, rare disorder of unknown etiology that affects children and young adults worldwide. Typically, it manifests with chronic, painless cervical lymphadenopathy, fever, leukocytosis, and elevated inflammatory markers [1] [2] [3] [4] [5] . The disease has a predilection for the lymph nodes in the head and neck. However, extranodal involvement is common and occurs in 28-43% of cases with manifestations in the upper respiratory tract, salivary glands, skin, bone, and central nervous system [1, 3, 4, 6] . Involvement of orbital soft tissue, eyelid, lacrimal gland, conjunctiva, cornea, and retina has been reported. Isolated extranodal manifestations are extremely rare [2, [7] [8] [9] [10] .
Case Report
A Latino man in his thirties presented to the emergency department with left eye redness and blurry vision. He had intermittent headache with vertical diplopia mainly on left gaze that had progressed over 3 months. One month prior to this presentation, he was diagnosed with viral conjunctivitis. His past medical history was noncontributory, and a review of systems was negative.
On examination, the patient's visual acuity was 20/20 on the right and 20/40 on the left. There was no relative afferent pupillary defect in the left eye, but he did have dyschromatopsia, mild upper eyelid edema, temporal injection, 3 mm of proptosis, and hypotropia of the left eye (Fig. 1a, b) . Furthermore, the patient had limited supraduction and abduction of the left eye. Confrontational visual fields were full, and his anterior segment slit-lamp examination was unremarkable except for conjunctival injection surrounding the palpebral lobe of the left lacrimal gland. Dilated fundoscopic examination was notable for optic disc edema in the left eye with mild hyperemia and chorioretinal folds (Fig. 1c) . The exam of the right eye was normal.
Computed tomography (CT) scanning of the orbits revealed a bulky soft tissue mass involving the superolateral left orbit, displacing the globe inferiorly and medially (Fig. 1d, e) . The mass was inseparable from the lacrimal gland and was associated with an adjacent focal lytic bony defect in the superolateral orbital wall (Fig. 1f, g ). An anterior orbitotomy with biopsy of the left lacrimal gland was performed. An eyelid crease incision was made and dissection was performed toward the superior orbital rim. A subperiosteal dissection plane was taken along the roof of the orbit to allow good exposure. The periorbita was entered over the lacrimal gland mass, and representative tissue was excised for pathology. Intraoperatively, the mass extended posterior to the lacrimal gland and was noted to be firm and rubbery in texture.
Histopathologic examination showed loss of normal lacrimal gland architecture, with periductular sclerosis and a prominent mixed inflammatory infiltrate, which was composed of histiocytes, small lymphocytes, scattered plasma cells, and neutrophils (Fig. 2a,  b) . Immunohistochemical studies disclosed a mixture of CD3-positive T lymphocytes (Fig. 2c) , CD20-positive B lymphocytes (Fig. 2d) , polytypic CD138-positive plasma cells (Fig. 2e) , and numerous CD68-and CD163-positive histiocytes (Fig. 2f) . S100 immunostaining demonstrated scattered large histiocytes with conspicuous emperipolesis (Fig. 2g, arrows and inset) . CD1a immunostaining was negative, revealing only rare dendritic cells. The histologic and immunophenotypic findings supported the diagnosis of sinus histiocytosis with massive lymphadenopathy (RDD).
The patient responded well to oral corticosteroid therapy (60 mg of prednisone) with improvement in his proptosis and hypoglobus and with complete resolution of optic neuropathy, diplopia, and headaches. He was then referred to the hematology department for further evaluation which did not reveal any systemic involvement. The patient received a repeat CT scan of the orbits 16 months following the surgery. The repeat CT scan (Fig. 1h) showed a decrease in the size of the mass, with sclerosis and remineralization of the adjacent bony defect (Fig. 1i, j) .
Discussion
RDD is a rare, self-limited, nonmalignant disease characterized by histiocytic infiltration of lymph nodes or extranodal tissue. The etiology of RDD remains unknown and is thought to be due to an idiopathic, uncontrolled histiocytic proliferation. Some reports have suggested a possible role for human herpes virus [5] , parvovirus B19 [11] , and Epstein-Barr virus [12] in the pathogenesis of the disease. However, no definite etiology has been established, and additional studies are needed. In the familial form of RDD, a germline mutation in SLC29A3, a gene that encodes intracellular equilibrative nucleoside transporter (hENT3), has been reported [13] . This suggests that the familial form of RDD may belong to a spectrum of disorders with SSLC29A3 mutations, including Faisalabad histiocytosis, H syndrome, and pigmented hypertrichosis with insulin-dependent diabetes mellitus [13] .
Gross pathology reveals specimens with a firm, rubbery consistency that are well-circumscribed with capsular or pericapsular fibrosis [14] . On microscopic examination, the hallmark findings of the disease are peripole-DOI: 10.1159/000489127 sis (lymphocytes surrounding the plasmalemma) and emperipolesis (the nondestructive phagocytosis of lymphocytes or erythrocytes by histiocytes [1, 6] ) (Fig. 2g) . In early nodal disease, the normal lymph node architecture is preserved; however, sinusoidal dilation occurs secondary to infiltration by histiocytes, lymphocytes, or plasma cells [1, 3, 6] . Eosinophils are rarely seen in this condition, in contrast to Langerhans cell histiocytosis (LCH), Hodgkin's lymphoma, or T-cell lymphoma [2, 5] . In extranodal RDD, increased fibrosis and fewer histiocytes are present in the lesions. Typically, the histiocytes demonstrate an abundant foamy or vacuolated eosinophilic cytoplasm with large, round, hypochromatic nuclei [2, 5] . Immunohistochemical stains are helpful in establishing the diagnosis. RDD histiocytes stain positively for CD68 (KP-1), CD163, and S100 and are typically negative for CD1a [5] . A negative stain with CD1a and absence of ultrastructural rod-shaped Birbeck granules help to distinguish RDD from LCH [15] .
Orbital involvement is very rare and can be an isolated extranodal manifestation or associated with concurrent systemic disease. In the largest case series of RDD published in 1979, 13 out of 113 cases (11%) had periocular infiltration [2] , with 11 of the 13 cases involving the orbital soft tissues. Involvement of orbital soft tissues and the eyelids is the most common reported ophthalmic manifestation. Involvement of the lacrimal gland (unilateral [9, 16] or bilateral [17] ), conjunctiva [7] , uvea [18] , cornea [8] , and retina [18] has been described. Orbital disease is generally associated with a higher risk of involvement of other extranodal sites, especially the sinonasal mucosa [2] .
Bony involvement is exceedingly rare in RDD, and symptoms typically include pain and swelling [6, 19] . There are 188 RDD patients with bone involvement reported in the literature [19] , and 35% (67/188) had primary RDD of the bone. The cranial and facial bones as well as long bones are the most frequently affected sites. Imaging usually demonstrates lytic lesions (53/67) and less commonly partially lytic and partially sclerotic lesions (12/67) [19] . We conducted a literature search of all cases of RDD involving the lacrimal gland (data summarized in Table  1 ). Including our patient, there were only 17 cases of RDD involving the lacrimal gland reported in the literature (Table 1 [9, 10, 16, 17, [20] [21] [22] [23] [24] [25] [26] [27] [28] ). The median age of these patients was 32 years (range 4-78). Thirteen out of 17 (76%) cases were male. The most common presentation was a painless orbital mass, followed by swelling of the eyelids and proptosis. Secondary optic neuropathy, as seen in our patient, has not been reported. Six out of the 17 patients (35%) displayed isolated lacrimal gland disease with no systemic involvement. The most common type of systemic involvement was cervical lymphadenopathy. Seven out of 17 patients demonstrated bilateral lacrimal gland involvement (41%), with 1 of these cases progressing from unilateral to bilateral disease. Bony involvement in RDD is extremely rare; there was only 1 other case in the literature of lacrimal gland involvement with adjacent bony lytic lesions. Our case is the first to demonstrate bony involvement that is not merely erosive but appears to excavate the orbital wall with a punchedout appearance.
The differential diagnosis of RDD is broad and depends on the site of anatomical involvement; it includes malignant and nonmalignant etiologies. Nonmalignant etiologies include tuberculosis, sarcoidosis, granulomatosis with polyangiitis, juvenile xanthogranuloma, LCH, Löffler's syndrome, and IgG4-related disease. Malignant etiologies include Hodgkin's lymphoma, non-Hodgkin's lymphoma, melanoma, leukemia, and Langerhans cell sarcoma. RDD of the orbit can mimic orbital pseudotumor, tuberculous granuloma, LCH, juvenile xanthogranuloma, rhabdomyosarcoma, Erdheim-Chester disease, meningioma, lymphoma, malignant histiocytosis, and reactive sinus hyperplasia. If the lacrimal gland is involved, dacryoadenitis and epithelial gland tumors must also be considered. Finally, when bony lesions are associated with lacrimal gland enlargement, as seen in our case, it is critical to rule out lacrimal gland adenocarcinoma, adenoid cystic carcinoma, granulocytic sarcoma (chloroma), benign (reactive) and malignant osteogenic tumors, and metastatic neuroblastoma in children.
RDD is a nonmalignant histiocytic disorder with an indolent and self-limited course in the majority of patients [3, 5, 14] . Patients diagnosed with RDD should undergo a thorough systemic evaluation. Treatment is usually not necessary in clinically stable patients as they often experience spontaneous resolution [29] . Complete surgical excision or debulking constitutes a first-line option for patients with nodal or extranodal disease affecting organ function, quality of life, or involving the central nervous system [3, 5, 14] . Systemic corticosteroids, chemotherapy, and radiation therapy can result in reduction of disease burden and durable remission in some cases [3, 5, 14] . On the other hand, a higher percentage of patients with orbital RDD required treatment as orbital involvement resulted in significant morbidity and visual compromise [30] .
Based upon our literature review of RDD with lacrimal gland involvement (Table 1) , surgical intervention with complete excision or debulking was the treatment of choice in 13 out of the 17 cases (76%) and resulted in complete resolution or improved residual disease. One case in addition to ours required additional oral corticosteroids to control residual disease. In 3 out of the 17 cases (17%) where surgical intervention was not possible, oral corticosteroids were sufficient to attain near complete resolution of symptoms. In 1 case, the signs and symptoms of RDD resolved in the absence of treatment.
The prognosis of RDD is usually favorable [6] . In 1 study, the mortality rate was estimated as high as 7%; however, only 2 cases were directly caused by the disease itself, and the rest could be attributed to complications of other defined immunologic abnormalities or infectious causes [31] . Coexistence of RDD with lymphoma [6, 14] and generalized AA amyloidosis [32] has been described; thus, routine surveillance is important to monitor for potential malignant transformation, systemic manifestation, and visual compromise.
Conclusion
Although rare, RDD should be considered in the differential diagnosis of an orbital mass involving the lacrimal gland with associated bone erosion, along with malignant lesions of the lacrimal gland. A referral to a medical oncologist or hematologist is recommended for evaluation and management of systemic involvement. Localized disease of the lacrimal gland is otherwise treated successfully with excision and/or systemic corticosteroids based upon our experience and a review of the cohort of subjects in the literature.
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